Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H H Chou

Showing results (61-70 of 68) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 68 results.
European Journal of Gynaecological Oncology|December 5, 2008
Prognostic factors and adjuvant therapy in uterine carcinosarcomaT I Wu, K H Hsu, H J Huang, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|October 3, 2006
The distribution and differential risks of human papillomavirus genotypes in cervical preinvasive lesions: A Taiwan Cooperative Oncologic Group StudyC-A Chen, C-Y Liu, H-H Chou, et al.
Chemical Communications (Cambridge, England)|May 20, 2014
Efficient delayed fluorescence via triplet-triplet annihilation for deep-blue electroluminescenceP-Y Chou, H-H Chou, Y-H Chen, et al.
Changgeng Yi Xue Za Zhi|December 16, 1998
Implications of a failed prospective trial of adjuvant therapy after radical hysterectomy for stage Ib-IIa cervical carcinoma with pelvic node metastasesC H Lai, S G Tang, T C Chang, et al.
Gynecologic Oncology|September 23, 1997
Retrograde lymphatic spread: a likely route for metastatic ovarian cancers of gastrointestinal originT C Chang, C C Changchien, C W Tseng, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 14, 2000
Randomized trial of neoadjuvant cisplatin, vincristine, bleomycin, and radical hysterectomy versus radiation therapy for bulky stage IB and IIA cervical cancerT C Chang, C H Lai, J H Hong, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 20, 2025
Rucaparib maintenance for newly diagnosed advanced ovarian cancer: interim overall survival, progression-free survival, and safety at 5 years of follow-up from the phase III ATHENA-MONO/GOG-3020/ENGOT-ov45 studyR S Kristeleit, S Ghamande, A Lisyanskaya, et al.
Science (New York, N.Y.)|March 24, 2000
A whole-genome assembly of DrosophilaE W Myers, G G Sutton, A L Delcher, et al.
Pageof 7

Showing results (61-70 of 68) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 68 results.
European Journal of Gynaecological Oncology|December 5, 2008
Prognostic factors and adjuvant therapy in uterine carcinosarcomaT I Wu, K H Hsu, H J Huang, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|October 3, 2006
The distribution and differential risks of human papillomavirus genotypes in cervical preinvasive lesions: A Taiwan Cooperative Oncologic Group StudyC-A Chen, C-Y Liu, H-H Chou, et al.
Chemical Communications (Cambridge, England)|May 20, 2014
Efficient delayed fluorescence via triplet-triplet annihilation for deep-blue electroluminescenceP-Y Chou, H-H Chou, Y-H Chen, et al.
Changgeng Yi Xue Za Zhi|December 16, 1998
Implications of a failed prospective trial of adjuvant therapy after radical hysterectomy for stage Ib-IIa cervical carcinoma with pelvic node metastasesC H Lai, S G Tang, T C Chang, et al.
Gynecologic Oncology|September 23, 1997
Retrograde lymphatic spread: a likely route for metastatic ovarian cancers of gastrointestinal originT C Chang, C C Changchien, C W Tseng, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 14, 2000
Randomized trial of neoadjuvant cisplatin, vincristine, bleomycin, and radical hysterectomy versus radiation therapy for bulky stage IB and IIA cervical cancerT C Chang, C H Lai, J H Hong, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 20, 2025
Rucaparib maintenance for newly diagnosed advanced ovarian cancer: interim overall survival, progression-free survival, and safety at 5 years of follow-up from the phase III ATHENA-MONO/GOG-3020/ENGOT-ov45 studyR S Kristeleit, S Ghamande, A Lisyanskaya, et al.
Science (New York, N.Y.)|March 24, 2000
A whole-genome assembly of DrosophilaE W Myers, G G Sutton, A L Delcher, et al.
Pageof 7